{"pub_date": "2016-04-28T00:00:00Z", "subsection_name": "DealBook", "lead_paragraph": "The crowding phenomenon comes amid a backdrop of turbulence for the hedge fund industry, where some of the biggest names have reported double-digit losses.", "print_page": "6", "document_type": "article", "byline": {"person": [{"rank": 1, "organization": "", "lastname": "STEVENSON", "firstname": "Alexandra", "role": "reported"}, {"rank": 2, "organization": "", "lastname": "GOLDSTEIN", "firstname": "Matthew", "role": "reported"}], "original": "By ALEXANDRA STEVENSON and MATTHEW GOLDSTEIN"}, "multimedia": [{"width": 190, "height": 126, "url": "images/2016/04/28/business/28DB-HERD/28DB-HERD-thumbWide.jpg", "subtype": "wide", "legacy": {"wide": "images/2016/04/28/business/28DB-HERD/28DB-HERD-thumbWide.jpg", "widewidth": "190", "wideheight": "126"}, "type": "image"}, {"width": 600, "height": 480, "url": "images/2016/04/28/business/28DB-HERD/28DEB-HERD-articleLarge.jpg", "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "480", "xlarge": "images/2016/04/28/business/28DB-HERD/28DEB-HERD-articleLarge.jpg"}, "type": "image"}, {"width": 75, "height": 75, "url": "images/2016/04/28/business/28DB-HERD/28DB-HERD-thumbStandard.jpg", "subtype": "thumbnail", "legacy": {"thumbnail": "images/2016/04/28/business/28DB-HERD/28DB-HERD-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "type": "image"}], "section_name": "Business Day", "headline": {"print_headline": "As Valeant Tumbles, So Does Billionaire\u2019s Hedge Fund Herd", "main": "As Valeant Tumbles, So Does Bill Ackman\u2019s Hedge Fund Herd"}, "source": "The New York Times", "blog": [], "word_count": "1333", "web_url": "http://www.nytimes.com/2016/04/28/business/dealbook/as-valeant-tumbles-so-does-billackmans-hedge-fund-herd.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "The crowding phenomenon comes amid a backdrop of turbulence for the hedge fund industry, where some of the biggest names have reported double-digit losses.", "_id": "57215bd738f0d83acb9a61f3", "abstract": "Pershing Square Capital Management founder William A Ackman testifies at Senate hearing on Valeant Pharmaceuticals' drug pricing policies; his hedge fund, along with others, have lost billions of dollars on Valeant, which has seen its share price plummet 85 percent since 2015.", "keywords": [{"rank": "1", "name": "subject", "value": "Hedge Funds", "is_major": "Y"}, {"rank": "2", "name": "persons", "value": "Ackman, William A", "is_major": "Y"}, {"rank": "3", "name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "Y"}, {"rank": "4", "name": "organizations", "value": "Pershing Square Capital Management", "is_major": "Y"}, {"rank": "5", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N"}, {"rank": "6", "name": "subject", "value": "Bankruptcies", "is_major": "N"}]}